
ABOUT ISR REPORTS
Industry Standard Research – ISR Reports – is a full-service market research company operating exclusively in the pharmaceutical and pharmaceutical services industry. ISR’s syndicated and custom market research capabilities coupled with unparalleled industry expertise and experience, enables our customers to make smarter, more informed business decisions.
ISR’s syndicated reports are produced using direct feedback from decision-makers (primary market research) which enables us to provide data on topics that, until now, were only attainable through custom research. With rigorous screening criteria and methodologies that include surveys, in-depth phone interviews, and focus groups, ISR gathers actionable information that is immediately applicable to our customers.
While our syndicated reports cover a wide-range of topics within the industry, sometimes clients have specific questions that need answering or they are searching for a certain target. ISR designs dozens of proprietary custom market research projects for clients every year. These studies are often used to assess new products and services, gauge customer satisfaction, measure brand strength, or test marketing messages.
ISR knows the industry. We have presented at bid defenses, owned P&Ls, written proposals to RFPs, designed and implemented marketing strategies, and negotiated strategic partnerships. These experiences translate to our work products. ISR operates exclusively in the pharmaceutical and pharmaceutical services industry, our knowledge of the space is current and detailed.
Give us a call or send us an email, we are always open to a conversation. If we can help we will, and if not, we will tell you.
You can also download our brochure here.
E-BOOKS
-
Discover how market research is empowering decision-makers while helping CDMOs tailor their strategies to better meet sponsor needs.
-
Take note of the characteristics experts should consider when selecting an IRT provider, what sponsors are using more than one CTMS solution, the future of EDC, and more.
-
As clinical trials become increasingly complex, it is more important than ever to understand how to overcome patient recruitment challenges in order to accelerate timelines, lower costs, and improve the quality of clinical trial data.
-
This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
-
Hybrid trials have undergone rapid evolution in the past few years. Examine this evolution, the reasons for confidence and concern, and how they may impact pharmaceutical development in the future.
-
It can be difficult to find industry specific, easy to interpret, trustworthy market data. Read the available eBook to discover free drug development and manufacturing facts, figures, and expert perspectives.
CONTACT INFORMATION
ISR Reports
5565 Centerview Drive
Raleigh, NC 27606
UNITED STATES
Phone: 919-301-0106
INFOGRAPHICS
- Phase II/III Outsourcing Partner Selection Attributes
- Desired Integrated Clinical Logistics Activities
- Top 5 improvements Needed In Today’s EDC Software Systems
- How To Improve eCOA/ePRO Software Systems
- Why Phase II/III Service Providers Lose Bids
- Patient Recruitment Challenges In Rare Disease Studies
- Central IRB Outsourcing Practices By Company Size
- Most Important Selection Criteria For Central IRB Services
- 3 Year Rolling Average – Phase I Service Provider Customer Loyalty
- Most Important Capabilities For Pharmacovigilance Services
- Preferred Provider Use Among Bioanalytical Lab Outsourcers
- Improving Clinical Logistics Outsourcing Relationships
- Top 5 Selection Attributes Gaining Importance For Outsourced Bioanalytical Lab Services
- Clinical Materials Distribution by Location
- 2018-2023 Edition Of The CRO Market Size Projections
- Most Important Attributes For EDC Provider Selection: Development vs. Post-Marketing
- Top 5 Selection Attributes For Outsourced eTMF Services
- The Impact Of mHealth Technologies On Clinical Trial Spending
- Preferred Provider Use For IRT Services
- Technology In Clinical Trials: Differences By Company Size
WEBINARS
FEATURED ARTICLES
- Slide Down The Funnel To Stand Out
- Phase II/III Outsourced Spend Across Provider Types
- The Future Of EDC Systems
- Advancing Clinical Research With Modern Technology
- Can’t Stop Us Now: CRO Growth Amid Uncertainty
- Win The Small And Emerging Sponsors’ Service Contracts
- Perspectives On Decentralized Trial Service Providers
- How Phase I CROs Can Meet Expectations By Understanding Drug Sponsor Needs
- Predictive Power Of Perceived Leadership
- How To Make Your CRO Stand Out Or Find That Perfect Fit
- Budget Management & Provider Selection Strategies For Phase I Clinical Development
- Considerations When Selecting An Interactive Response Technology Provider
- Decentralized Clinical Trials: Evolving Post-Pandemic
- Cryobag Container Development For Cell & Gene Therapies
- Industry Trends: CDMO Outsourcing
- 2022 CRO Leadership Awards Results
- Industry Trends: Clinical Logistics Outsourcing
- Outsourcers Send A Consistent Message In Phase 2/3 CRO Selection
- How Service Providers Can Create Momentum In An Established Brand
- Outsourcers Are Feeling Uneasy About Continuity Of Supply
- Why Are Sponsor Organizations Using More Than 1 CTMS Solution?
- Central Labs And Outsourcing: An Overview
- What’s Happening In Cell & Gene Therapy Development?
- Company Size And PPAs – Peeling The Layers Of Phase II/III Service Provider Selection
- What To Prioritize When Selecting A Phase 1 CRO
- Message To CROs: Keep That Pandemic Tool Belt Handy
- How CROs Can Increase Proposal Success Rates Through Win/Loss Studies
- IRB Performance And Best Practices In Site Start-up: Review Of Two Recent Market Research Reports
- Finding A Glass Slipper Service Provider To Fit Your Phase II/III Outsourcing Needs
- Decision-making Responsibilities When Outsourcing Late-Phase Studies
- Can CROs Rise To The Patient Access & Recruitment Challenge?
- Rare Disease Studies: A Comfortable Patient Is A Retained Patient
- Industry Trends In Clinical Development Technology
- The Quest To Improve Efficiency In Site Contract And Budget Negotiations
- Can Integrated Service Providers Help Simplify Complex Clinical Trial Logistics?
- How Will mHealth Benefit Clinical Trials?
- Hybrid Trials Are Here To Stay
- Insights Into The Competitive Clinical Manufacturing Market
- Top 5 Challenges In Finding Rare Disease Patients
- Influence Of Size In CRO Selection
- Trends In Clinical Development
- Attributes Gaining Importance In Clinical Research
- CRO Selection Taken Seriously
- Old Dog, New Tricks: How Pharma Is Innovating With Existing Technologies
- Provider Selection In Small And Emerging Pharma Companies
- Fast Track To Flexible Clinical Trials
- Finding the Clinical Development Outsourcing Model That Is Just Right
- Warming Up To Hybrid Trials